Login to Your Account

Macrogenics Pops on Debut; Trevena Joins IPO Queue

By Jennifer Boggs
Managing Editor

Friday, October 11, 2013
In another piece of good news for the biotech initial public offering (IPO) market, Macrogenics Inc. priced its IPO as expected Thursday, selling 5 million shares at $16 apiece, and then watched as shares (NASDAQ:MGNX) opened 53 percent higher on the first day of trading.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription